Skingevity Bolsters Leadership Team with Two Key Executive Appointments

Skingevity, a London-based medical clinic group, has expanded its leadership team with two new high-profile appointments. The company, which currently operates five clinics worldwide, is strengthening its management as part of a UK-first strategy with global ambitions.

Dr. Paul Eccleston has joined Skingevity as Chief Medical Officer. In this role, he will oversee governance, education, and professional development across the company's clinics. His appointment comes as the firm looks to refine its medical standards and operational practices.

The company is led by co-CEOs with strong corporate backgrounds. Marco Agnolio, who serves as co-CEO and chief operating officer, previously worked as a principal at The Boston Consulting Group. Alongside him, co-CEO and CFO Alessandro Ghio brings experience from his time as an executive director at Goldman Sachs.

Skingevity's five clinics are spread across key international locations. These include Dubai in the United Arab Emirates, Berlin and Munich in Germany, Zurich in Switzerland, and Miami in the USA. The London headquarters coordinates operations while pursuing further expansion.

With its new leadership in place, Skingevity aims to solidify its position in the medical clinic sector. The appointments of Eccleston, Agnolio, and Ghio signal a focus on governance, operational efficiency, and strategic growth. The company continues to balance its UK roots with a widening global footprint.